• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • Bullous Pemphigoid Learning Hub
    • COPD Learning Hub
    • Rhinology Learning Hub
    • Type 2 Asthma Learning Hub
    • Prurigo Nodularis Learning Hub
    • Atopic Dermatitis Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: IsraelChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Prurigo nodularis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
Epidemiology and Pathophysiology of AD in Children
Dermatology
2 min
expert video

Epidemiology and Pathophysiology of AD in Children

Identification and Management of AD Uncontrolled With Topical Therapies in Children
Dermatology
3 min
expert video

Identification and Management of AD Uncontrolled With Topical Therapies in Children

Loss of Smell is a Key Symptom of CRSwNP
Rhinology
5 min
interactivity

Loss of Smell is a Key Symptom of CRSwNP

Understanding IL-33: A Key Factor in COPD Pathogenesis
Pulmonology
5 min
interactivity

Understanding IL-33: A Key Factor in COPD Pathogenesis

Tailored Medicine in COPD: Understanding Phenotypes, Endotypes, and Genotypes
Pulmonology
5 min
interactivity

Tailored Medicine in COPD: Understanding Phenotypes, Endotypes, and Genotypes

Learn more about how dysregulated type 2 inflammation contributes to polymorphous lesions and dermal epidermal splitting in bullous pemphigoid
Dermatology
4 min
Infographic

Bullous Pemphigoid (BP) Pathophysiology Infographic

Type 2 Inflammation Within Skin Tissue in AD
Dermatology
4 min
expert video

Type 2 Inflammation Within Skin Tissue in AD

CCL17 (TARC): A Key Player and Biomarker in Atopic Dermatitis
Dermatology
5 min
Infographic

CCL17 (TARC): A Key Player and Biomarker in Atopic Dermatitis

IL-4 Contributes to Systemic Type 2 Inflammation in AD
Dermatology
4 min
expert video

IL-4 Contributes to Systemic Type 2 Inflammation in AD

Latest Real-World Data on Advanced Systemic Treatments for Patients With AD
Dermatology
13 min
expert video

Latest Real-World Data on Advanced Systemic Treatments for Patients With AD

The Importance of Early Intervention and the Potential for Disease Modification in Patients With AD
Dermatology
15 min
expert video

The Importance of Early Intervention and the Potential for Disease Modification in Patients With AD

Diving Below the Surface of AD: The Role of Type 2 Inflammation
Dermatology
10 min
expert video

Diving Below the Surface of AD: The Role of Type 2 Inflammation

    1
    ...
    8910
    ...
    21